NASDAQ •
Healthcare •
Diagnostics & Research •
Quote as of 07/24/2026
Company Profile
IndustryDiagnostics & Research
SectorHealthcare
ExchangeNASDAQ
Market Capitalization224.51 mln
Float4.69 mln
Earnings Date08/05/2026
Piotroski F-Score
5
/ 9
Neutral
Beneish M-Score
-2.73
Likely reliable
1-Year Forecast
30.83
Exceptional upside
Relative Strength
88
/ 100
Strongly outperforming
Debt / Equity
7.84
Extremely leveraged
ROE
-932
Deeply negative
Business Description
Biodesix is a medical diagnostics company based in Louisville, Colorado, focused on helping doctors detect and manage lung cancer through blood-based testing. Its key products help identify whether lung nodules are likely to be cancerous and guide treatment decisions by analyzing tumor mutations and immune system activity. The company also supports pharmaceutical and life sciences firms with services ranging from early biomarker research through to clinical trial testing and regulatory assistance. Founded in 2005, Biodesix operates its own laboratories and has built its business around making lung cancer diagnosis faster and more precise.